1 / 5

Aim

Postdeployment symptom changes and traumatic brain injury and/or posttraumatic stress disorder in men. Caroline A. Macera, PhD; Hilary J. Aralis, MS; Andrew J. MacGregor, PhD; Mitchell J. Rauh, PhD, PT, MPH; Michael R. Galarneau, MS. Aim

fia
Download Presentation

Aim

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Postdeployment symptom changes and traumatic brain injury and/orposttraumatic stress disorder in men Caroline A. Macera, PhD; Hilary J. Aralis, MS; Andrew J. MacGregor, PhD; Mitchell J. Rauh, PhD, PT, MPH; Michael R. Galarneau, MS

  2. Aim • Evaluate effect of traumatic brain injury (TBI) and/or posttraumatic stress disorder (PTSD) screening status on development and persistence of symptoms across 2 time points following return from deployment. • Relevance • Without clear understanding of postdeployment symptom development and persistence, symptom overlap can’t be accurately addressed and informed decisions about diagnosis, treatment, and prognosis are limited.

  3. Method • Using data from Post-Deployment Health Assessment and Reassessment, we identified 12,046 male U.S. Navy sailors and Marines with reported combat exposure from 2008 to 2009. • Symptoms present immediately after deployment were compared with symptoms present several months later for servicemembers who screened positive for blast-related TBI and/or PTSD.

  4. Results • Subjects with PTSD, blast-related TBI, or both experienced development or worsening of symptoms during months following return from deployment. • Those who screened positive for both PTSD and TBI reported increased symptoms for most postdeployment health symptom categories, except for musculoskeletal symptoms.

  5. Conclusion • Providers should consider reevaluating patients, even those who initially appear asymptomatic. • Importance of follow-up evaluation should be recognized. • Clinicians may want to communicate to patients who are evaluated as having experienced TBI and/or PTSD that treatments will focus on specific symptoms rather than diagnostic labels.

More Related